Phase III Multicenter Trial: Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy after Breast Conserving Surgery for Low-Risk Invasive Carcinoma and Low-Risk Ductal Carcinoma In-Situ of the Female Breast – One-Year Toxicities

Brachytherapy ◽  
2013 ◽  
Vol 12 ◽  
pp. S15 ◽  
Author(s):  
Vratislav Strnad ◽  
Oliver J. Ott ◽  
Guido Hildebrandt ◽  
Helen Knauerhase ◽  
Richard Pötter ◽  
...  
Keyword(s):  
Invasive Carcinoma ◽  
Ductal Carcinoma ◽  
Breast Conserving Surgery ◽  
Multicenter Trial ◽  
Low Risk ◽  
Phase Iii ◽  
External Beam Radiation ◽  
Beam Radiation ◽  
One Year

Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?

2020 ◽  
Vol 27 (11) ◽  
pp. 4459-4465 ◽  
Author(s):  
Tawakalitu O. Oseni ◽  
Barbara L. Smith ◽  
Constance D. Lehman ◽  
Charmi A. Vijapura ◽  
Niveditha Pinnamaneni ◽  
...  
Keyword(s):  
Active Surveillance ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Invasive Carcinoma ◽  
Ductal Carcinoma ◽  
Low Risk ◽  
Eligibility Criteria

scholarly journals Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

2016 ◽  
Vol 23 (11) ◽  
pp. 3487-3493 ◽  
Author(s):  
Melissa Pilewskie ◽  
Michelle Stempel ◽  
Hope Rosenfeld ◽  
Anne Eaton ◽  
Kimberly J. Van Zee ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Patient Population ◽  
Carcinoma In Situ ◽  
Invasive Carcinoma ◽  
Ductal Carcinoma ◽  
Low Risk ◽  
Eligibility Criteria
Sign in / Sign up

Export Citation Format

Share Document